Skip to main content
# Title Research Member Research Year
221 Impact of treatment-related toxicity on
outcome of HCV-positive diffuse large B-cell
lymphoma in rituximab era
Dr. Amen Hamdy Zaki Ali 2014
222 Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment Dr. Mayada Fawzy Sedik Farghaly 2014
223 The role of Circulating Tumor Cells (CTCs) in
Predicting the Response of Primary (Neoadjuvant)
Chemotherapy and its Impact as a Prognostic Factor in
Early Breast Cancer









































Prof. Ashraf Zeidan Abdalla Ahmed 2014
224 Risk Factors for Recurrent CMV Reactivation in CMV Seropositive Recipients Following T Cell Depleted Haematopoietic Stem Cell Transplantation Dr. Abeer Elsayed Ali Ibrahim 2014
225 • The impact of radiotherapy and concomitant weekly cisplatin on treatment outcome of locally advanced nasopharyngeal carcinoma Dr. Ashraf Mohamed El-Yamany 2013
226 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard?

Dr. Adel Gomaa Mohamed Gabr 2013
227 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard?

Dr. Abeer Elsayed Ali Ibrahim 2013
228 ECF with Infusional Fluorouracil for 5 Days in Locally Advanced and Metastatic Gastric Cancer, Is It Better than the Standard? Dr. Adel Gomaa Mohamed Gabr 2013
229 Prognostic value of regulatory T cells in newly diagnosed
chronic myeloid leukemia patients
Dr. Abeer Elsayed Ali Ibrahim 2013
230 Sphincter Saving Surgeries for Locally Advanced Low Rectal Cancer after Neoadjuvant Chemoradiation Dr. Abeer Elsayed Ali Ibrahim 2013